Jun Wei

发表

D. Duggan, Jianfeng Xu, S. Zheng, 2019 .

Association of prostate cancer polygenic risk score with number and laterality of tumor cores in active surveillance patients

Jianfeng Xu, P. Walsh, W. Isaacs, 2021, The Prostate.

Sickle Cell Trait and Risks for Common Diseases: Evidence from the UK Biobank.

Jianfeng Xu, S. Zheng, B. Helfand, 2022, The American journal of medicine.

Reliability of Ancestry-specific Prostate Cancer Genetic Risk Score in Four Racial and Ethnic Populations

K. Cooney, Jianfeng Xu, W. Isaacs, 2022, European urology open science.

Statistical evidence for high‐penetrance MODY‐causing genes in a large population‐based cohort

M. Udler, L. Billings, T. Pollin, 2022, Endocrinology, diabetes & metabolism.

Reclassification of coronary artery disease risk using genetic risk score among subjects with borderline or intermediate clinical risk

B. Helfand, P. Hulick, L. Billings, 2022, International journal of cardiology. Heart & vasculature.

Association of germline rare pathogenic mutations in guideline‐recommended genes with prostate cancer progression: A meta‐analysis

K. Cooney, Jianfeng Xu, S. Zheng, 2021, The Prostate.

Association of Reported Candidate Monogenic Genes With Lung Cancer Risk.

B. Helfand, P. Hulick, S. Krantz, 2023, Clinical lung cancer.

Distinct Genomic Alterations in Prostate Tumors Derived from African American Men

Jianfeng Xu, Wennuan Liu, Jishan Sun, 2020, Molecular Cancer Research.

Inherited risk assessment and its clinical utility for predicting prostate cancer from diagnostic prostate biopsies

Jianfeng Xu, W. Isaacs, S. Zheng, 2022, Prostate Cancer and Prostatic Diseases.

Performance of Three Inherited Risk Measures for Predicting Prostate Cancer Incidence and Mortality: A Population-based Prospective Analysis.

D. Duggan, K. Cooney, Jianfeng Xu, 2020, European urology.

Validation of a prostate cancer polygenic risk score

Jianfeng Xu, S. Zheng, K. Wiley, 2020, The Prostate.

Observed evidence for guideline‐recommended genes in predicting prostate cancer risk from a large population‐based cohort

K. Cooney, Jianfeng Xu, W. Isaacs, 2021, The Prostate.

The HOXB13 variant X285K is associated with clinical significance and early age at diagnosis in African American prostate cancer patients

K. Cooney, Jianfeng Xu, P. Walsh, 2021, British Journal of Cancer.

Longitudinal Monitoring of Parkinson's Disease in Different Ethnic Cohorts: The DodoNA and LONG-PD Study

D. Maraganore, K. Wirdefeldt, E. Dardiotis, 2020, Frontiers in Neurology.

Shared Inherited Genetics of Benign Prostatic Hyperplasia and Prostate Cancer

Jianfeng Xu, W. Isaacs, B. Helfand, 2021, medRxiv.

Association of rare, recurrent nonsynonymous variants in the germline of prostate cancer patients of African ancestry

K. Cooney, P. Walsh, W. Isaacs, 2022, The Prostate.

KLK3 germline mutation I179T complements DNA repair genes for predicting prostate cancer progression

K. Cooney, Jianfeng Xu, W. Isaacs, 2022, Prostate Cancer and Prostatic Diseases.

Germline HOXB13 G84E mutation carriers and risk to twenty common types of cancer: results from the UK Biobank

K. Cooney, Jianfeng Xu, W. Isaacs, 2020, British Journal of Cancer.

Systematic review of reported association studies of monogenic genes and bladder cancer risk and confirmation analysis in a large population cohort

B. Helfand, A. Glaser, James T. Kearns, 2022, BJUI compass.

Variable Effects of PD-Risk Associated SNPs and Variants in Parkinsonism-Associated Genes on Disease Phenotype in a Community-Based Cohort

D. Maraganore, A. Pham, R. Frigerio, 2021, Frontiers in Neurology.

Assessing the performance of genetic risk score for stratifying risk of post-sepsis cardiovascular complications

S. Zheng, B. Helfand, Zhuqing Shi, 2023, Frontiers in Cardiovascular Medicine.

Association of Sickle Cell Trait with Risk and Mortality of COVID-19: Results from the UK Biobank

Jianfeng Xu, S. Zheng, B. Helfand, 2020, medRxiv.

Association of Sickle Cell Trait with Risk and Mortality of COVID-19: Results from the United Kingdom Biobank

Jianfeng Xu, S. Zheng, B. Helfand, 2021, The American journal of tropical medicine and hygiene.

Cystic fibrosis F508del carriers and cancer risk: Results from the UK Biobank

Jianfeng Xu, S. Zheng, B. Helfand, 2020, International journal of cancer.

The Prostate

D. Duggan, B. Helfand, Z. Mo, 2019 .

Calibration of polygenic risk scores is required prior to clinical implementation: results of three common cancers in UKB

D. Duggan, Jianfeng Xu, S. Zheng, 2020, Journal of Medical Genetics.

Cancer-associated thrombosis by cancer sites and inherited factors in a prospective population-based cohort.

D. Duggan, S. Zheng, B. Helfand, 2023, Thrombosis research.

Association of sickle cell trait with adverse pregnancy outcomes in a population‐based cohort

B. Helfand, M. Caplan, J. Morgan, 2023, Acta obstetricia et gynecologica Scandinavica.

Utility of polygenic scores for differentiating diabetes diagnosis among patients with atypical phenotypes of diabetes.

S. Zheng, B. Helfand, P. Hulick, 2023, The Journal of clinical endocrinology and metabolism.

Using gene and gene-set association tests to identify lethal prostate cancer genes.

Zhuqing Shi, Jun Wei, C. Carroll, 2024, Prostate cancer and prostatic diseases.

Refining Risk for Alzheimer's Disease Among Heterozygous APOEɛ4 Carriers.

D. Duggan, S. Zheng, B. Helfand, 2023, Journal of Alzheimer's disease : JAD.

Genetic Susceptibility for Low Testosterone in Men and Its Implications in Biology and Screening: Data from the UK Biobank

Jianfeng Xu, W. Isaacs, S. Zheng, 2021, European urology open science.